China Resources Sanjiu Medical & Pharmaceutical Co Ltd (SHE:000999) — Market Cap & Net Worth
Market Cap & Net Worth: China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999)
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (SHE:000999) has a market capitalization of $6.31 Billion (CN¥43.12 Billion) as of May 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #3073 globally and #428 in its home market, demonstrating a -5.37% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying China Resources Sanjiu Medical & Pharmaceutical Co Ltd's stock price CN¥25.91 by its total outstanding shares 1664217858 (1.66 Billion). Analyse how efficiently does China Resources Sanjiu Medical & Pharmac generate cash to see how efficiently the company converts income to cash.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Market Cap History: 2015 to 2026
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $4.32 Billion to $6.31 Billion (4.26% CAGR).
Index Memberships
China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Shanghai Shenzhen CSI 300
CSI300
|
$4.18 Trillion | 0.15% | #122 of 285 |
Weight: China Resources Sanjiu Medical & Pharmaceutical Co Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how China Resources Sanjiu Medical & Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.39x
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's market cap is 0.39 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.21x
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's market cap is 3.21 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $4.32 Billion | $7.90 Billion | $1.25 Billion | 0.55x | 3.46x |
| 2016 | $3.94 Billion | $8.98 Billion | $1.20 Billion | 0.44x | 3.29x |
| 2017 | $4.36 Billion | $11.12 Billion | $1.30 Billion | 0.39x | 3.35x |
| 2018 | $4.05 Billion | $13.43 Billion | $1.43 Billion | 0.30x | 2.83x |
| 2019 | $5.23 Billion | $14.79 Billion | $2.10 Billion | 0.35x | 2.49x |
| 2020 | $4.18 Billion | $13.64 Billion | $1.60 Billion | 0.31x | 2.61x |
| 2021 | $5.85 Billion | $15.54 Billion | $2.06 Billion | 0.38x | 2.84x |
| 2022 | $8.17 Billion | $18.08 Billion | $2.45 Billion | 0.45x | 3.34x |
| 2023 | $8.82 Billion | $24.74 Billion | $2.85 Billion | 0.36x | 3.09x |
| 2024 | $10.80 Billion | $27.62 Billion | $3.37 Billion | 0.39x | 3.21x |
Competitor Companies of 000999 by Market Capitalization
Companies near China Resources Sanjiu Medical & Pharmaceutical Co Ltd in the global market cap rankings as of May 4, 2026.
Key companies related to China Resources Sanjiu Medical & Pharmaceutical Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.09 |
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, China Resources Sanjiu Medical & Pharmaceutical Co Ltd's market cap moved from $4.32 Billion to $ 6.31 Billion, with a yearly change of 4.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥6.31 Billion | -8.96% |
| 2025 | CN¥6.93 Billion | -35.81% |
| 2024 | CN¥10.80 Billion | +22.37% |
| 2023 | CN¥8.82 Billion | +7.98% |
| 2022 | CN¥8.17 Billion | +39.78% |
| 2021 | CN¥5.85 Billion | +39.99% |
| 2020 | CN¥4.18 Billion | -20.19% |
| 2019 | CN¥5.23 Billion | +29.23% |
| 2018 | CN¥4.05 Billion | -7.10% |
| 2017 | CN¥4.36 Billion | +10.59% |
| 2016 | CN¥3.94 Billion | -8.88% |
| 2015 | CN¥4.32 Billion | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of China Resources Sanjiu Medical & Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.31 Billion USD |
| MoneyControl | $6.31 Billion USD |
| MarketWatch | $6.31 Billion USD |
| marketcap.company | $6.31 Billion USD |
| Reuters | $6.31 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About China Resources Sanjiu Medical & Pharmaceutical Co Ltd
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products,… Read more